Median Technologies SA

Update in progress

ALMDT.PA (Paris)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Median Technologies SA provides medical imaging products and services for diagnosing and monitoring cancer in routine clinical practice and during clinical drug development. It operates in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive imaging-based cancer diagnostics; and iCRO, a central imaging service with an AI-powered Imaging Lab. Focuses on oncology trials and cancer patient care. Founded 2002, based in Valbonne, France.

Company score

Sentiment: 0.44; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.23; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.11; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.09; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.27; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive